Cited by

• Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms.

  Guo H, Yang J, Wang H, Liu X, Liu Y, Zhou K. Guo H, et al. Front Immunol. 2022 Oct 12;13:1017990. doi: 10.3389/fimmu.2022.1017990. eCollection 2022. Front Immunol. 2022. PMID: 36311747 Free PMC article. Review.
• Response and Survival Estimates of Patients With Plasma Cell Myeloma in a Resource-Constrained Setting Using Protocols From High-Income Countries: A Single-Center Experience From Sri Lanka.

  Hewamana S, Gunasena P, Jayasinghe C, Skandarajah T, Harischandra M, Abeyaratne S, Ekanayake L, Somasundaram G, Somiah S, Srinivasan V, Arseculeratne G, Perera N, Fernando J, Faiz M, Munasinghe N, Mowlana A, Deshapriya S, Mawathakubura S, Wickramarathna C, Wijewickrama A, Jayawardena P, Perera E, Peiris N, Paranawithane S, Perera C, Kariyawasam C, Munasinghe S, De Silva C, Wadanamby R, Galagoda G, Lin TT, Wijesiriwardena B, Balawardena J. Hewamana S, et al. JCO Glob Oncol. 2022 Jun;8:e2100352. doi: 10.1200/GO.21.00352. JCO Glob Oncol. 2022. PMID: 35772042 Free PMC article.
• Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing.

  Bahmad HF, Demus T, Moubarak MM, Daher D, Alvarez Moreno JC, Polit F, Lopez O, Merhe A, Abou-Kheir W, Nieder AM, Poppiti R, Omarzai Y. Bahmad HF, et al. Med Sci (Basel). 2022 Feb 18;10(1):15. doi: 10.3390/medsci10010015. Med Sci (Basel). 2022. PMID: 35225948 Free PMC article. Review.
• Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up.

  Vasquez J, Ruiz R, Aliaga K, Valencia F, Villena M, Quintana S, Vidaurre T, Casanova L. Vasquez J, et al. JCO Glob Oncol. 2021 Jul;7:1199-1205. doi: 10.1200/GO.20.00665. JCO Glob Oncol. 2021. PMID: 34297605 Free PMC article.
• Overcoming cancer therapeutic bottleneck by drug repurposing.

  Zhang Z, Zhou L, Xie N, Nice EC, Zhang T, Cui Y, Huang C. Zhang Z, et al. Signal Transduct Target Ther. 2020 Jul 2;5(1):113. doi: 10.1038/s41392-020-00213-8. Signal Transduct Target Ther. 2020. PMID: 32616710 Free PMC article. Review.